These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo. Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990 [TBL] [Abstract][Full Text] [Related]
6. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Ram Z; Culver KW; Walbridge S; Blaese RM; Oldfield EH Cancer Res; 1993 Jan; 53(1):83-8. PubMed ID: 8380127 [TBL] [Abstract][Full Text] [Related]
7. Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir. Namba H; Tagawa M; Miyagawa T; Iwadate Y; Sakiyama S Cancer Gene Ther; 2000 Jun; 7(6):947-53. PubMed ID: 10880027 [TBL] [Abstract][Full Text] [Related]
8. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase. Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394 [TBL] [Abstract][Full Text] [Related]
9. Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions. Sandmair AM; Turunen M; Tyynelä K; Loimas S; Vainio P; Vanninen R; Vapalahti M; Bjerkvig R; Jänne J; Ylä-Herttuala S Cancer Gene Ther; 2000 Mar; 7(3):413-21. PubMed ID: 10766347 [TBL] [Abstract][Full Text] [Related]
10. Gene therapy of rat C6 glioma using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene: long-term follow-up by magnetic resonance imaging. Maron A; Gustin T; Le Roux A; Mottet I; Dedieu JF; Brion JP; Demeure R; Perricaudet M; Octave JN Gene Ther; 1996 Apr; 3(4):315-22. PubMed ID: 8732163 [TBL] [Abstract][Full Text] [Related]
11. Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo. Tjuvajev JG; Chen SH; Joshi A; Joshi R; Guo ZS; Balatoni J; Ballon D; Koutcher J; Finn R; Woo SL; Blasberg RG Cancer Res; 1999 Oct; 59(20):5186-93. PubMed ID: 10537296 [TBL] [Abstract][Full Text] [Related]
12. Radiosensitization of rat glioma with bromodeoxycytidine and adenovirus expressing herpes simplex virus-thymidine kinase delivered by slow, rate-controlled positive pressure infusion. Brust D; Feden J; Farnsworth J; Amir C; Broaddus WC; Valerie K Cancer Gene Ther; 2000 May; 7(5):778-88. PubMed ID: 10830725 [TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated gene therapy in an experimental model of breast cancer metastatic to the brain. Colak A; Goodman JC; Chen SH; Woo SL; Grossman RG; Shine HD Hum Gene Ther; 1995 Oct; 6(10):1317-22. PubMed ID: 8590736 [TBL] [Abstract][Full Text] [Related]
14. [Gene therapy of a model of glioblastoma in rats using adenovirus vector encoding the HSVtk gene]. Quillien V; Heresbach Le Berre N; Dufour T; Denais A; Guegan Y; Ferry N; Bloin V Bull Cancer; 1997 Nov; 84(11):1047-52. PubMed ID: 9536986 [TBL] [Abstract][Full Text] [Related]
15. HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma. Moriuchi S; Krisky DM; Marconi PC; Tamura M; Shimizu K; Yoshimine T; Cohen JB; Glorioso JC Gene Ther; 2000 Sep; 7(17):1483-90. PubMed ID: 11001368 [TBL] [Abstract][Full Text] [Related]
16. Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene. Boviatsis EJ; Park JS; Sena-Esteves M; Kramm CM; Chase M; Efird JT; Wei MX; Breakefield XO; Chiocca EA Cancer Res; 1994 Nov; 54(22):5745-51. PubMed ID: 7954393 [TBL] [Abstract][Full Text] [Related]
17. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo. Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477 [TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model. O'Malley BW; Chen SH; Schwartz MR; Woo SL Cancer Res; 1995 Mar; 55(5):1080-5. PubMed ID: 7866992 [TBL] [Abstract][Full Text] [Related]
19. Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine. Okada H; Giezeman-Smits KM; Tahara H; Attanucci J; Fellows WK; Lotze MT; Chambers WH; Bozik ME Gene Ther; 1999 Feb; 6(2):219-26. PubMed ID: 10435106 [TBL] [Abstract][Full Text] [Related]
20. Enhanced cytotoxicity of antiviral drugs mediated by adenovirus directed transfer of the herpes simplex virus thymidine kinase gene in rat glioma cells. Shewach DS; Zerbe LK; Hughes TL; Roessler BJ; Breakefield XO; Davidson BL Cancer Gene Ther; 1994 Jun; 1(2):107-12. PubMed ID: 7621241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]